Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03694431
Other study ID # PLC-1609-36108
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 7, 2019
Est. completion date January 24, 2020

Study information

Verified date February 2020
Source Kaiser Permanente
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: To effectively alleviate suffering and improve quality of life for patients with serious illness and their caregivers, palliative care (PC) services must be offered across multiple settings. Research is needed to determine how best to optimize home-based palliative care (HBPC) services to meet the needs of individuals with high symptom burden and functional limitations.

Aim: The investigators will compare a standard HBPC model that includes routine home visits by a nurse and provider with a more efficient tech-supported HBPC model that promotes timely inter-professional team coordination via synchronous video consultation with the provider while the nurse is in the patient's home. The investigators hypothesize that tech-supported HBPC will be as effective as standard HBPC.

Design: Cluster randomized trial. Registered nurses (n~130) will be randomly assigned to the tech-supported or standard HBPC model so that half of the patient-caregiver dyads will receive one of the two models.

Setting/Participants: Kaiser Permanente (15 Southern California and Oregon sites). Patients (n=10,000) with any serious illness and a prognosis of 1-2 years and their caregivers (n=4,800)

Methods: Patients and caregivers will receive standard PC services: comprehensive needs assessment and care planning, pain and symptom management, education/skills training, medication management, emotional/spiritual support; care coordination, referral to other services, and 24/7 phone assistance.

Results: Primary patient outcomes: symptom improvement at 1 month and days spent at home in the last six months of life; caregiver outcome: perception of preparedness for caregiving.

Conclusion: Should the more efficient tech-supported HBPC model achieves comparable improvements in outcomes that matter most to patients and caregivers, this would have a lasting impact on PC practice and policy.


Recruitment information / eligibility

Status Terminated
Enrollment 3999
Est. completion date January 24, 2020
Est. primary completion date January 24, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Patient Inclusion Criteria:

- Serious illness with 12-24 month life expectancy

- Homebound

- Need for skilled nursing care (only at KP Southern California)

- English or Spanish speakers

Patient Exclusion Criteria:

- Currently receiving HBPC

Caregiver Inclusion Criteria:

- Non-professional family, friend or other caregiver

- English or Spanish speakers

Study Design


Intervention

Other:
Tech-supported HBPC
Palliative care provided consistent with recommendations from the National Consensus Project for Quality Palliative Care
Standard HBPC
Palliative care provided consistent with recommendations from the National Consensus Project for Quality Palliative Care

Locations

Country Name City State
United States Kaiser Permanente Southern California Pasadena California
United States Kaiser Permanente Northwest Portland Oregon

Sponsors (2)

Lead Sponsor Collaborator
Kaiser Permanente Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Symptom severity (total score) using the Edmonton Symptom Assessment Scale (ESAS) The ESAS is a 10-item survey measuring symptom severity. Scores range from 0-100 with higher scores indicating worse symptoms. Change from baseline to 1 month
Primary Days at home in the last 180 days of life among patients surviving at least 180 days after enrolling in HBPC Baseline to 12 months
Primary Caregiver preparedness for caregiving using the Preparedness for Caregiving Scale The Preparedness for Caregiving Scale is a 9-item survey measuring caregivers' perception of their preparedness for caregiving. Scores range from 0-36 with higher scores indicating higher perception of preparedness Change from baseline to 1 month
Secondary Days at home between study enrollment and death or study completion (365 days) Variable, up to 12 months
Secondary Patient quality of life measured with the PROMIS-10 survey The PROMIS-10 is a 10-item survey measuring general health related quality of life. Scores range from 0-100 with higher scores indicating better quality of life Change from baseline to 1 and 6 months
Secondary Patient general distress measured with the distress thermometer Scores for this single item distress thermometer range from 0-10 with higher scores indicating greater distress Change from baseline to 1 and 6 months
Secondary Palliative performance scale will be measured using all data available from routine clinical practice as documented in the electronic medical record (EMR) The Palliative Performance Scale measures overall functional status. A clinician completes this assessment using a scale of 0-100 with higher scores indicating better functional performance Baseline and variable time periods due to reliance on available data from the EMR
Secondary Patient satisfaction-care experience measured by a study-specific survey This 8-item satisfaction-care experience survey was developed specifically to measure satisfaction and care experience with home-based palliative care. 1 and 6 months
Secondary Patient acute and post-acute care utilization Frequency of hospitalizations, emergency department visits and skilled nursing facility stay Baseline to 12 months
Secondary Patient outpatient health care utilization Frequency of primary and specialty care visits Baseline to 12 months
Secondary Patient enrollment in and days on hospice before death Baseline to 12 months
Secondary Patient death Baseline to 12 months
Secondary Caregiver quality of life measured with the PROMIS-10 The PROMIS-10 is a 10-item survey measuring general health related quality of life. Scores range from 0-100 with higher scores indicating better quality of life Change from baseline to 1 and 6 months
Secondary Caregiver burden measured with the Zarit-12 Caregiver Burden Scale The Zarit-12 is a 12-item survey measuring caregiver burden. Scores range from 0-48 with higher scores indicating greater caregiver burden Change from baseline to 1 and 6 months
Secondary Caregiver acute and post-acute care utilization Frequency of hospitalizations, emergency department visits and skilled nursing facility stay for caregivers who are members of Kaiser Permanente Baseline to 12 months
Secondary Caregiver outpatient health care utilization Frequency of primary and specialty care visits for caregivers who are members of Kaiser Permanente Baseline to 12 months
Secondary HBPC clinician perception of facilitators and barriers to implementation of HBPC services Study specific survey (under development) Yearly, up to four years
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases